Compounds > n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide

n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide and gefitinib

n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide has been researched along with gefitinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, G; Dang, YW; He, RQ; Luo, DZ; Xiong, DD; Xu, WQ	1

Other Studies

1 other study(ies) available for n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide and gefitinib

Article	Year
In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme. Oncology reports, 2019, Volume: 41, Issue:4 Topics: Androstadienes; Antineoplastic Agents; Brain Neoplasms; Computational Biology; Drug Discovery; Gefitinib; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Glioblastoma; Humans; MicroRNAs; Molecular Docking Simulation; Molecular Targeted Therapy; Sulfonamides; Transcriptome	2019

Article

Year

In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.

Oncology reports, 2019, Volume: 41, Issue:4

Topics: Androstadienes; Antineoplastic Agents; Brain Neoplasms; Computational Biology; Drug Discovery; Gefitinib; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Glioblastoma; Humans; MicroRNAs; Molecular Docking Simulation; Molecular Targeted Therapy; Sulfonamides; Transcriptome

2019